AleraCare Rebrands
Nationally

Kisunla™ – New FDA-Approved Alzheimer’s Treatment Now Available at AleraCare

August 2024 Kisunla™ – New FDA-Approved Alzheimer’s Treatment Now Available at AleraCare We are thrilled to announce that AleraCare’s Scottsdale, AZ Ambulatory Infusion Center has become one of the first facilities in the nation to administer Kisunla™ Kisunla™ (donanemab-azbt), the latest FDA-approved treatment for early-stage Alzheimer’s disease. Our patient’s journey was notably featured on Arizona’s […]

Hildred Capital Management Completes Strategic Investment in AleraCare

Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers

AleraCare Rebrands Nationally

Consolidates Ambulatory Infusion, Specialty Pharmacy, Home Infusion and Compounding Pharmacy Service Lines